Bloodstream infections in patients given treatment with intravenous prostanoids (Q30228937)

11 June 2017

Bloodstream infections in patients given treatment with intravenous prostanoids (English)

1 reference

11 June 2017

1

Alexander J Kallen

1 reference

11 June 2017

3

Alexandra Balaji

1 reference

11 June 2017

10

Robyn J Barst

1 reference

11 June 2017

Edith Lederman

2

1 reference

11 June 2017

Ingrid Trevino

4

1 reference

11 June 2017

Emily E Petersen

5

1 reference

11 June 2017

Rivka Shoulson

6

1 reference

11 June 2017

Lisa Saiman

7

1 reference

11 June 2017

Evelyn M Horn

8

1 reference

11 June 2017

Mardi Gomberg-Maitland

9

1 reference

11 June 2017

Arjun Srinivasan

11

1 reference

11 June 2017

language of work or name

1 reference

1 April 2008

1 reference

Infection Control and Hospital Epidemiology

11 June 2017

1 reference

11 June 2017

29

1 reference

11 June 2017

4

1 reference

11 June 2017

342-349

1 reference

Inhibition of intracellular tumour necrosis factor (TNF)-alpha and interleukin (IL)-6 production in human monocytes by iloprost

11 June 2017

1 reference

Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin) administered by the intravenous and subcutaneous route to normal volunteers

21 January 2018

1 reference

Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial

21 January 2018

1 reference

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

21 January 2018

1 reference

Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension

21 January 2018

1 reference

Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension

21 January 2018

1 reference

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

21 January 2018

1 reference

Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.

21 January 2018

1 reference

Prostacyclin analogs suppress the synthesis of tumor necrosis factor-alpha in LPS-stimulated human peripheral blood mononuclear cells

21 January 2018

1 reference

Prostacyclin inhibits adhesion of polymorphonuclear leukocytes to human vascular endothelial cells due to adhesion molecule independent regulatory mechanisms

21 January 2018

1 reference

Current treatment strategies for pulmonary arterial hypertension

21 January 2018

1 reference

The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies.

21 January 2018

1 reference

Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension

21 January 2018

1 reference

Micrococcus Infection in Patients Receiving Epoprostenol by Continuous Infusion

21 January 2018

1 reference

Synthetic Prostacyclin Analogs Differentially Regulate Macrophage Function via Distinct Analog-Receptor Binding Specificities

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/529552

1 reference

11 June 2017

1 reference